Harvard Bioscience (HBIO) Acquires AHN Biotechnologie GmbH
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Join SI Premium – FREE
Harvard Bioscience, Inc. (Nasdaq: HBIO), has acquired the business of AHN Biotechnologie GmbH through its wholly owned Biochrom Ltd. subsidiary.
AHN is a privately held manufacturer of plastic consumable laboratory products including pipette tips. This acquisition is complementary to the current Biochrom product line of molecular biology instruments.
AHN is a privately held manufacturer of plastic consumable laboratory products including pipette tips. This acquisition is complementary to the current Biochrom product line of molecular biology instruments.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- Vireo Growth completes acquisition of C21 Investments
- Magna Holdings makes unsolicited bid for 31% of Yatra Online
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
